Cliques for the identification of gene signatures for colorectal cancer across population

BMC Systems Biology

Volumn 6, Issue SUPPL3, 2012, Pages

  Pradhan, Meeta P ^a   Nagulapalli, Kshithija ^a   Palakal, Mathew J ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ARTICLE; BIOLOGY; CHINA; COLORECTAL TUMOR; FEEDING BEHAVIOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; GERMANY; HUMAN; METHODOLOGY; MICROARRAY ANALYSIS; PATHOLOGY; POPULATION GENETICS; SAUDI ARABIA; SIGNAL TRANSDUCTION; UNITED STATES;

CHINA; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; FOOD HABITS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENETICS, POPULATION; GERMANY; HUMANS; MICROARRAY ANALYSIS; SAUDI ARABIA; SIGNAL TRANSDUCTION; TRANSCRIPTOME; UNITED STATES;

MLCS; MLOWN;

EID: 84896369544     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-6-S3-S17     Document Type: Article

References (97)

1. Burkitt D. Possible relationships between bowel cancer and dietary habbits. Proc R Soc Med 1971, 64:964-5. 1812841, 5114307.
2. Sridhar R, et al. A molecular signature of metastasis in primary solid tumors. Nature Genetics 2003, 33:49-54. 10.1038/ng1060, 12469122.
3. Rhodes DR, et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004, 101(25):9309-14. 10.1073/pnas.0401994101, 438973, 15184677.
4. Kavak E, et al. Meta-analysis of cancer gene expression signatures reveals new cancer genes, SAGE tags and tumor associated regions of co-regulation. Nucleic Acids Research 2010, 38(20):7008-21. 10.1093/nar/gkq574, 2978353, 20621981.
5. Xu L, Geman D, Winslow RL. Large-scale integration of cancer microarray data identifies a robust common cancer signature. BMC Bioinformatics 2007, 8:275. 10.1186/1471-2105-8-275, 1950528, 17663766.
6. Axelsen JB, et al. Genes overexpressed in different human solid cancers exhibit different tissue-specific expression profiles. Proc Natl Acad Sci USA 2007, 104(32):13122-7. 10.1073/pnas.0705824104, 1941809, 17664417.
7. Altman RB, Raychaudhuri S. Whole-genome expression analysis: challenges beyond clustering. Current Opinion in Structural Biology 2001, 11(3):340-347. 10.1016/S0959-440X(00)00212-8, 11406385.
8. Golub T, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. Science 1999, 286(5439):531-537. 10.1126/science.286.5439.531, 10521349.
9. Alizadeh AA, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403(6769):503-11. 10.1038/35000501, 10676951.
10. Bernards R, et al. A gene-expression signature as a predictor of survival in breast cancer. New England Journal of Medicine 2002, 347(25):1999-2009. 10.1056/NEJMoa021967, 12490681.
11. Beer DG, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002, 8(8):816-24.
12. Andrisani OM, Studach L, Merle P. Gene signatures in hepatocellular carcinoma (HCC). Semin Cancer Biol 2011, 21(1):4-9. 10.1016/j.semcancer.2010.09.002, 3030925, 20851183.
13. Jurchott K, et al. Identification of Y-Box Binding Protein 1 As a Core Regulator of MEK/ERK Pathway-Dependent Gene Signatures in Colorectal Cancer Cells. Plos Genetics 2010, 6(12):e1001231. 10.1371/journal.pgen.1001231, 2996331, 21170361.
14. Fu LM, Fu-Liu CS. Multi-class cancer subtype classification based on gene expression signatures with reliability analysis. Febs Letters 2004, 561(1-3):186-190. 10.1016/S0014-5793(04)00175-9, 15013775.
15. Ideker T, Ozier O, Schwikowski B, Siegal AF. Discovering regulatory and signaling circuits in molecular interaction networks. Bioinformatics 2002, 18(Suppl 1):S233-S240. 10.1093/bioinformatics/18.suppl_1.S233, 12169552.
16. Oda K. Targeting Ras-PI3K/mTOR pathway and the predictive biomarkers in endometrial cancer. Gan To Kagaku Ryoho 2011, 38(7):1084-7.
17. Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 2008, 7(10):827-40. 10.1038/nrd2660, 18827826.
18. Andersen JN, et al. Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors. Sci Transl Med 2010, 2(43):43ra55. 10.1126/scitranslmed.3001065, 20686178.
19. Zhang F, Chen JY. Discovery of pathway biomarkers from coupled proteomics and systems biology methods. BMC Genomics 2010, 11(Suppl 2):S12. 10.1186/1471-2164-11-S2-S12, 3005917, 21143795.
20. Bandyopadhyay N, et al. Pathway-based feature selection algorithm for cancer microarray data. Adv Bioinformatics 2009, 532989. PMC2831238, 20204186.
21. Muller H, et al. Graph-based identification of cancer signaling pathways from published gene expression signatures using PubLiME. Nucleic Acids Research 2007, 35(7):2343-2355. 10.1093/nar/gkm119, 1874632, 17389643.
22. Bild AH, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006, 439(7074):353-357. 10.1038/nature04296, 16273092.
23. Chuang HY, et al. Network-based classification of breast cancer metastasis. Mol Syst Biol 2007, 3:140. 2063581, 17940530.
24. Li J, et al. Identification of high-quality cancer prognostic markers and metastasis network modules. Nature Communications 2010, 1(4):1-8.
25. Swami M. CANCER GENOMICS A modular approach to signalling. Nature Reviews Genetics 2009, 10(6):348-348.
26. Hartwell LH, et al. From molecular to modular cell biology. Nature 1999, 402(6761 Suppl):C47-52.
27. Ulitsky I, Shamir R. Identification of functional modules using network topology and high-throughput data. BMC Systems Biology 2007, 1:8. 10.1186/1752-0509-1-8, 1839897, 17408515.
28. Maraziotis IA, Dimitrakopoulou K, Bezerianos A. Growing functional modules from a seed protein via integration of protein interaction and gene expression data. BMC Bioinformatics 2007, 8:408. 10.1186/1471-2105-8-408, 2233647, 17956603.
29. Tornow S, Mewes HW. Functional modules by relating protein interaction networks and gene expression. Nucleic Acids Research 2003, 31(21):6283-9. 10.1093/nar/gkg838, 275479, 14576317.
30. Dittrich MT, et al. Identifying functional modules in protein-protein interaction networks: an integrated exact approach. Bioinformatics 2008, 24(13):i223-31. 10.1093/bioinformatics/btn161, 2718639, 18586718.
31. Chen TC, et al. Cliques in mitotic spindle network bring kinetochore-associated complexes to form dependence pathway. Proteomics 2009, 9(16):4048-62. 10.1002/pmic.200900231, 19658104.
32. Hu H, Yan X, Huang Y, Han J, Zhou X. Mining coherent dense subgraphs across massive biological networks for functional discovery. Bioinformatics 2005, 21(Suppl 1):i213-i221. 10.1093/bioinformatics/bti1049, 15961460.
33. Shen Q-J-B. Maximum-clique algorithm: an Effective Method to Mine Large-scale Co-expressed Genes in Arabidopsis Anther. Proceeding of the 30th Chinese Control Conference 2011,
34. Wu H, et al. Prediction of functional modules based on comparative genome analysis and Gene Ontology application. Nucleic Acids Research 2005, 33(9):2822-37. 10.1093/nar/gki573, 1130488, 15901854.
35. Zhao S, Li Y. Extracting functional modules from biological pathways. Nature precedings 2007, 1457:1.
36. Li Y, Agarwal P, Rajagopalan D. A global pathway crosstalk network. Bioinformatics 2008, 24(12):1442-1447. 10.1093/bioinformatics/btn200, 18434343.
37. Clements M, et al. Integration of known transcription factor binding site information and gene expression data to advance from co-expression to co-regulation. Genomics Proteomics Bioinformatics 2007, 5(2):86-101. 10.1016/S1672-0229(07)60019-9, 17893074.
38. Storey JD, et al. Gene-expression variation within and among human populations. Am J Hum Genet 2007, 80(3):502-509. 10.1086/512017, 1821107, 17273971.
39. Minguez P, Dopazo J. Assessing the Biological Significance of Gene Expression Signatures and Co-Expression Modules by Studying Their Network Properties. PLOs One 2011, 6(3):e17474. 10.1371/journal.pone.0017474, 3049771, 21408226.
40. Mao LY, et al. Arabidopsis gene co-expression network and its functional modules. BMC Bioinformatics 2009, 10:346. 10.1186/1471-2105-10-346, 2772859, 19845953.
41. Jovov B, Araujo-Perez F, Sigel CS, Stratford JK, McCoy AN, Yeh JJ, Keku T. Differential Gene Expression between African American and European American Colorectal Cancer Patients. PLOs One 2012, 7(1):e30168. 10.1371/journal.pone.0030168, 3261881, 22276153.
42. Koyuturk M, et al. Detecting conserved interaction patterns in biological networks. J Comput Biol 2006, 13(7):1299-322. 10.1089/cmb.2006.13.1299, 17037960.
43. Mostafavi S, et al. GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function. Genome Biol 2008, 9(Suppl 1):S4. 10.1186/gb-2008-9-s1-s4, 2559988, 18834495.
44. Shi Z, Derow CK, Zhang B. Co-expression module analysis reveals biological processes, genomic gain, and regulatory mechanisms associated with breast cancer progression. Bmc Systems Biology 2010, 4:74. 10.1186/1752-0509-4-74, 2902438, 20507583.
45. Cerami E, et al. Automated Network Analysis Identifies Core Pathways in Glioblastoma. PLoS One 2010, 5(2):e8918. 10.1371/journal.pone.0008918, 2820542, 20169195.
46. Prasad TSK, et al. Human Protein Reference Database-2009 update. Nucleic Acids Research 2009, 37:D767-D772. 10.1093/nar/gkn892, 2686490, 18988627.
47. Bolstad BM, et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19(2):185-93. 10.1093/bioinformatics/19.2.185, 12538238.
48. Pradhan MP, Prasad NK, Palakal MJ. A Systems Biology Approach to the Global Analysis of Transcription Factors in Colorectal Cancer. BMC Cancer 2012, 12:331. 10.1186/1471-2407-12-331, 22852817.
49. Xiang H, Wang Q, Hu Z, Xu J, Wang W, Wei Z. Expression of EGFR, Grb2, p-mTOr and VEGFR in human colorectal cancer. Academic Journal of Second Military Medical University 2009, 29(7):775-779.
50. Seiden-Long I, Navab R, Shih W, Li M, Chow J, Zhu CQ, Radulovich N, Caroline Saucier C, Tsao MS. Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells. Carcinogenesis 2008, 29(3):647-655.
51. Vaughan TY, Verma S, Bunting KD. Grb2-associated binding (Gab) proteins in hematopoietic and immune cell biology. Am J Blood Res 2011, 1(2):130-134. 3232456,3232456, 22163099.
52. Bryan EJ, et al. Mutation analysis of EP300 in colon, breast and ovarian carcinomas. Int J Cancer 2002, 102(2):137-41. 10.1002/ijc.10682, 12385008.
53. Kanehisa M. KEGG: Kyoto Enclyopedia of Genes and Genomes. Nucleic Acids Research 2000, 28:27-30. 10.1093/nar/28.1.27, 102409, 10592173.
54. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular datasets. Nucleic Acids Research 2012, 40:D109-D114. 10.1093/nar/gkr988, 3245020, 22080510.
55. Lee Y, et al. ATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarization. Dev Cell 2011, 21(4):746-57. 10.1016/j.devcel.2011.08.017, 3253850, 22014525.
56. Cohen SJ, Cohen RB, Meropol NJ. Targeting signal transduction pathways in colorectal cancer - More than skin deep. Journal of Clinical Oncology 2005, 23(23):5374-5385. 10.1200/JCO.2005.02.194, 15998904.
57. Waldner M, Schimanski CC, Neurath MF. Colon cancer and the immune system: the role of tumor invading T cells. World J Gastroenterol 2006, 12(45):7233-8.
58. Ambs S, et al. Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. Journal of the National Cancer Institute 1999, 91(1):86-88. 10.1093/jnci/91.1.86, 9890175.
59. Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncology 2005, 6(5):322-327. 10.1016/S1470-2045(05)70168-6, 15863380.
60. Danning He Z-PL, Luonan C. Identification of dysfunctional modules and disease genes in congential heart disease by a network-based approach. BMC Genomics 2011, 12:592. 10.1186/1471-2164-12-592, 3256240, 22136190.
61. Xu Y, Pasche B. TGF-beta signaling alterations and susceptibility to colorectal cancer. Hum Mol Genet 2007, 16(Spec No 1):R14-20. 2637552, 17613544.
62. Ray RM, Bhattacharya S, Johnson LR. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1. Apoptosis 2011, 16(1):35-44. 10.1007/s10495-010-0538-0, 20812030.
63. Pradhan MP, Palakal MJ. Identifying CRC specific pathways and drug targets from literature augmented proteomics data. Proceedings of BioCOMP 2010, II:323-329.
64. Boyle EI, et al. GO::TermFinder - open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics 2004, 20(18):3710-3715. 10.1093/bioinformatics/bth456, 3037731, 15297299.
65. Dennis G, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4(5):P3. 10.1186/gb-2003-4-5-p3, 12734009.
66. Valentini AM, Pirrelli M, Caruso ML. EGFR-targeted therapy in colorectal cancer: Does immunohistochemistry deserve a role in predicting the response to cetuximab?. Current Opinion in Molecular Therapeutics 2008, 10(2):124-131.
67. Shankaran V, Obel J, Benson AB. Predicting response to EGFR inhibitors in metastatic colorectal cancer: current practice and future directions. Oncologist 2010, 15(2):157-67. 10.1634/theoncologist.2009-0221, 3227936, 20133499.
68. Bardelli A, Siena S. Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer. J Clin Oncol 2010, 28(7):1254-1261. 10.1200/JCO.2009.24.6116, 20100961.
69. Horii J, et al. Methylation of estrogen receptor 1 in colorectal adenomas is not age-dependent, but is correlated with K-ras mutation. Cancer Science 2009, 100(6):1005-1011. 10.1111/j.1349-7006.2009.01140.x, 19302287.
70. Mlakar V, et al. Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer. Bmc Cancer 2009, 9:282. 10.1186/1471-2407-9-282, 2745427, 19678923.
71. Lockwood W, Chari R, Coe BP, Girard L, MacAulay C, Lam S, Gazdar AF, Minna JD, Lam WL. DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers. Oncogene 2008, 27(33):4615-4624. 10.1038/onc.2008.98, 2849646, 18391978.
72. Ishihama K, et al. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas. J Clin Pathol 2007, 60(11):1205-10. 10.1136/jcp.2005.029165, 2095491, 17720775.
73. Suchy J, et al. BRCA1 mutations and colorectal cancer in Poland. Fam Cancer 2010, 9(4):541-4. 10.1007/s10689-010-9378-x, 20862552.
74. Xie W, Rimm DL, Lin Y, Shhih WJ, Reiss M. Loss of Smad Signaling in Human Colorectal cancer is associated with advanced disease and poor prognosis. Cancer Journal 2003, 9(4):302-312.
75. Li F, Cao Y, Townsend CM, Ko CK. TGF-b Signaling in Colon Cancer Cells. World Journal of Surgery 2005, 29(3):306-11. 10.1007/s00268-004-7813-6, 15711891.
76. Rodrigues NR, et al. P53 Mutations in Colorectal-Cancer. Proceedings of the National Academy of Sciences of the United States of America 1990, 87(19):7555-7559. 10.1073/pnas.87.19.7555, 54786, 1699228.
77. Schmitz M, et al. PCR-SSCP a sensitive and rapid method to detect mutations in the P53 tumor suppressor gene of patients with advanced colorectal cancer. European Journal of Cancer 1995, 31A:448-448.
78. Liu Y, Bodmer WF. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(4):976-981. 10.1073/pnas.0510146103, 1327731, 16418264.
79. Wu J, Lin W, Chen W, Huang Y, Tang C, Ho MS, Pi H, Chien C. CSN-mediated deneddylation differentially modulates Ci155 proteolysis to promote Hedgehog signalling responses. Nat Commun 2011, 2:182. 3105314, 21304511.
80. Chene P. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat Rev Cancer 2003, 3(2):102-9. 10.1038/nrc991, 12563309.
81. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol 2004, 22(22):4632-42. 10.1200/JCO.2004.07.151, 15542813.
82. Lim J, et al. Isolation of murine and human homologues of the fission-yeast dis3+ gene encoding a mitotic-control protein and its overexpression in cancer cells with progressive phenotype. Cancer Res 1997, 57(5):921-5.
83. Francisco M, Philippe L, Torben F, Karin B. Genes Involved in Human Ribosome Biogenesis are Transcriptionally Upregulated in Colorectal Cancer. Scholarly Research Exchange 2009, 2009. Article ID 657042.
84. Takahashi S, Suzuki S, Inaguma S, Cho Y-M, Ikeda Y, Hayashi N, Inoue T, Sugimura Y, Nishiyama N, Fujita T, Ushijima T, Shirai T. Down-regulation of Lsm1 is involved in human prostate cancer progression. Br J Cancer 2002, 86(6):940-946. 10.1038/sj.bjc.6600163, 2364150, 11953827.
85. Coovert D, Thanh T, Morris GE, Man NT, Kralewski M, Sendtner M, Burghes AHM. Does the survival motor neuron protein (SMN) interact with Bcl-2?. J Med Genet 2000, 37:536-539. 10.1136/jmg.37.7.536, 1734632, 10970187.
86. Pristauz G, et al. Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations. Histopathology 2010, 57(6):877-84. 10.1111/j.1365-2559.2010.03724.x, 21166701.
87. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000, 103(2):311-320. 10.1016/S0092-8674(00)00122-7, 11057903.
88. Torsello A, et al. P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: Distribution and prognostic relevance. European Journal of Cancer 2008, 44(9):1217-1222. 10.1016/j.ejca.2008.03.002, 18424032.
89. Hembruff SL, Cheng N. Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting. Cancer Ther 2009, 7(A):254-267. 2907742, 20651940.
90. So EY, Ouchi T. The application of Toll like receptors for cancer therapy. International Journal of Biological Sciences 2010, 6(7):675-681. 2974170, 21060729.
91. Huang MY, et al. CDC25A, VAV1, TP73, BRCA1 and ZAP70 gene overexpression correlates with radiation response in colorectal cancer. Oncology Reports 2011, 25(5):1297-306.
92. Kimura J, et al. A functional genome-wide RNAi screen identifies TAF1 as a regulator for apoptosis in response to genotoxic stress. Nucleic Acids Research 2008, 36(16):5250-5259. 10.1093/nar/gkn506, 2532742, 18684994.
93. Amundson SA, et al. Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Res 2008, 68(2):415-24. 10.1158/0008-5472.CAN-07-2120, 18199535.
94. Ogino S, Kawasaki T, Kirkner GJ, Ogawa A, Dorfman I, Loda M, fuchs CS. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer. J Pathol 2006, 210(2):147-54. 10.1002/path.2030, 16850502.
95. Patil A, Nakai K, Kinoshita K. Assessing the utility of gene co-expression stability in combination with correlation in the analysis of protein-protein interactions. BMC Genomics 2011, 12(Suppl 3):S19. 10.1186/1471-2164-12-S3-S19, 3333178, 22369639.
96. Martin D, et al. GOToolBox: functional analysis of gene datasets based on Gene Ontology. Genome Biol 2004, 5(12):R101. 10.1186/gb-2004-5-12-r101, 545796, 15575967.
97. Wang J, Chen G, Li M, Pan Y. Integration of breast cancer gene signatures based on graph centrality. Bmc Systems Biology 2011, 5(Suppl 3):S10. 10.1186/1752-0509-5-S3-S10, 3287565, 22784616.